Inhibikase Therapeutics Inc (IKT)

Investing Cash Flow

-$115.24M

TTM · Period ending: · USD

IKT logo

IKT Investing Cash Flow

Latest reported-$115.24M
IKT Cash from Investing ($0.00 → -$115.24M)
High-resolution chart · PNG

IKT investing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
2,053,130
-37,004,201
11,656,666
-16,005,708
0
0
0
87,097
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.